Senate Medical Affairs Committee Amendment
H 3592 - Session 125 (2023-2024)
Compounding pharmacies

The Committee on Medical Affairs proposes the following amendment (SR-3592.JG0002S):

Amend the bill, as and if amended, by adding appropriately numbered SECTIONS to read:

SECTION X. Section 40-43-30 of the S.C. Code is amended by adding:

(93) "Outsourcing facility" means a facility registered with the United States Food and Drug Administration to operate under Section 503B of the Federal Food and Cosmetic Act.

SECTION X. Chapter 43, Title 40 of the S.C. Code is amended by adding:

 Section 40-43-197. Any person or entity authorized to dispense drugs, including, but not limited to, a pharmacy, institutional pharmacy, or practitioner, may:
 (1) purchase or otherwise acquire drugs compounded or repackaged by an outsourcing facility directly from the outsourcing facility without an order from a practitioner other than, when applicable, the practitioner purchasing or acquiring the drug; and
 (2) administer and dispense drugs purchased or acquired pursuant to item (1) to the same extent as drugs acquired through other authorized means.